Basilea Pharmaceutica's market cap is currently CHF550.56M. The company's EPS TTM is CHF1.26; its P/E ratio is 7.56; Basilea Pharmaceutica is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is CHF1.73. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CHF
Basilea Pharmaceutica Earnings and Revenue History
